CGC(Canopy Growth Corporation) · 财务报表

CGC(Canopy Growth Corporation) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-03-31FY 截至 2023-03-31FY 截至 2024-03-31FY 截至 2025-03-31FY 截至 2026-03-31
营业收入$378.44M$250.17M$220.16M$192.75M$206.43M
毛利润−$149.10M−$47.69M$59.93M$56.97M$50.53M
营业利润−$810.50M−$1.97B−$169.46M−$83.94M−$117.25M
净利润−$246.65M−$2.46B−$513.97M−$364.63M−$190.69M
经营现金流−$434.22M−$418.55M−$208.90M−$118.77M−$46.28M
自由现金流−$463.40M−$425.39M−$211.46M−$126.52M−$50.15M
摊薄每股收益$-6.30$-53.07$-6.87$-3.39$-0.64

Canopy Growth Corporation CGC